Durvalumab Triplet Improves OS Across Biliary Tract Cancer Locations
August 24th, 2022
Dr. Aiwu Ruth He discusses her recent Biliary Tract Cancer Research that was featured in NEJM Evidence…
Save the Date
The Ruesch Center will hold its thirteenth annual symposium on November 18- 19, 2022.
Stay Up-to-date on Ruesch Activities
Hear from Ruesch faculty and learn about recent research highlights.
Reetu Mukherji, MD Joins Ruesch Faculty
She specializes in the treatment of Upper GI cancers and research on novel drug development.
A Candid Tour Through the World of Cancer
Dr. Marshall and his wife Liza, share their unique story in this recently published book.
Gastrointestinal (GI) Cancers are the most common and most fatal of all cancers. The Ruesch Center will re-focus national efforts on curing this deadly set of diseases.
Caring for the whole person: Learn how a multi-disciplinary approach drives patient-centered care at The Ruesch Center for the Cure of Gastrointestinal Cancers
Medical Costs and Clinical Value: Playing the Long Game
August 11th, 2022
Even as soaring medical costs strain public and private budgets around the world, patients yearn for therapeutic breakthroughs. Game-changing cancer treatments, emerging antiviral agents, and mRNA vaccines are powerful reminders of medical technology’s potential. But insurance premiums and out-of-pocket payments underscore medicine’s financial burden.…
Durvalumab Plus Chemotherapy Maintains OS Benefit in Advanced Biliary Tract Cancer
July 11th, 2022
Dr. Aiwu Ruth He discusses her biliary tract cancer research presented at ESMO GI…
Sign Up to receive all Ruesch updates directly in your Inbox
We will deliver our quarterly newsletter, monthly updates and other announcements to your Inbox with information on upcoming special events, current clinical trials and cutting edge research and trends in the GI cancer field.